 |
市場調查報告書
商品編碼
1865285
腎臟病市場規模、佔有率、成長分析（按類型、適應症、診斷、治療方法、年齡層和地區分類）－2025-2032年產業預測Hydronephrosis Market Size, Share, and Growth Analysis, By Type (Unilateral hydronephrosis, Bilateral hydronephrosis), By Indication (Intrinsic, Extrinsic), By Diagnosis, By Treatment, By Age Group, By Region - Industry Forecast 2025-2032 |
||||||
全球腎臟病市場預計在 2023 年達到 23 億美元，從 2024 年的 24.2 億美元成長到 2032 年的 36 億美元，在預測期（2025-2032 年）內複合年成長率為 5.1%。
泌尿系統阻塞（例如腎結石、先天性畸形和腫瘤）發生率的上升正顯著影響全球腎臟病市場。這些疾病會阻礙尿液流動，導致腎臟腫脹和功能受損，促使患者尋求診斷和治療方法方案，包括微創技術和外科手術。生活方式的改變、飲食習慣的改變以及人口老化等因素共同推動了全球對先進腎臟病管理解決方案的需求。同時，超音波、 電腦斷層掃描和MRI等先進影像技術的廣泛應用，使得對腎臟結構進行精確、非侵入性的檢查成為可能，從而實現早期診斷和適當干預，減少併發症並改善患者預後。價格合理的影像設備的日益普及也進一步推動了該市場的發展，促進了成長並創造了投資機會。
全球腎臟病市場促進因素
全球腎臟病市場的主要驅動力是泌尿系統阻塞（例如腎結石、先天性疾病和腫瘤）盛行率的上升。這些疾病會導致儲存、腎臟腫大和腎功能受損，增加了對創新診斷技術和高效治療方法的需求。隨著醫療系統努力應對這些挑戰，對尖端解決方案的需求持續推動全球市場的擴張。人們對腎臟病管理的認知和關注度不斷提高，進一步推動了該細分市場的成長，凸顯了及時干預和先進護理策略的重要性。
限制全球腎臟病市場的因素
全球腎臟病市場面臨許多限制因素，其中之一是大眾對腎臟疾病的認知不足，以及許多開發中國家早期篩檢計畫的覆蓋範圍有限。這種認知不足導致診斷延誤，進而降低腎臟病治療的有效性。由於及時發現對於最佳干預至關重要，治療效果的降低抑制了對先進診斷和治療方案的需求。因此，這些因素對服務不足地區的市場成長和擴張構成重大挑戰，限制了全球腎臟病市場的整體發展。
全球腎臟病市場趨勢
全球腎臟病市場正呈現出一個顯著的趨勢，即越來越重視兒科護理，尤其是在先天性尿路阻塞的治療方面。人工智慧輔助影像技術和早期篩檢方法的進步徹底改變了檢測能力，使得對嬰幼兒進行及時、準確的干涉成為可能。這種對兒科護理的日益重視不僅有助於改善腎臟的長期健康狀況，也拓寬了可供選擇的專業治療方案的範圍。因此，這一趨勢為針對兒科族群的創新診斷和治療解決方案創造了巨大的市場機會，從而提升了整個腎臟病市場的成長潛力。
目錄
介紹
- 調查目標
- 調查範圍
- 定義
調查方法
- 資訊收集
- 二手資料和一手資料方法
- 市場規模預測
- 市場假設與限制
執行摘要
- 全球市場展望
- 供需趨勢分析
- 細分市場機會分析
市場動態與展望
- 市場概覽
- 市場規模
- 市場動態
- 促進因素和機遇
- 限制與挑戰
- 波特分析
關鍵市場考察
- 關鍵成功因素
- 競爭程度
- 重大投資機會
- 市場生態系統
- 市場吸引力指數（2024）
- PESTEL 分析
- 總體經濟指標
- 價值鏈分析
- 定價分析
全球腎臟病市場規模（按類型和複合年成長率分類）（2025-2032 年）
- 市場概覽
- 單側腎臟病
- 雙側腎臟病
全球腎臟病市場規模（按適應症和複合年成長率分類）（2025-2032 年）
- 市場概覽
- 內源性
- 急性單側阻塞性泌尿道疾病
- 腎結石
- 膀胱癌
- 膀胱結石
- 尿道狹窄
- 骨盆器官脫垂
- 其他內源性指標
- 外源性
- 腹膜後纖維化
- 卵巢靜脈症候群
- 其他外源性適應症
全球腎臟病市場規模（按診斷和複合年成長率分類）（2025-2032 年）
- 市場概覽
- 實驗室測試
- 尿液檢查
- 血液常規檢查
- 電解質分析
- 其他測試
- 影像診斷
- 超音波
- 靜脈腎盂造影
- KUB X光檢查
- 電腦斷層掃描
- 其他成像方式
全球腎臟病市場規模（按治療方法和複合年成長率分類）（2025-2032 年）
- 市場概覽
- 體外震波碎石術
- 腹腔鏡手術
- 膀胱導尿術
- 類固醇療法
- 其他治療方法
全球腎臟病市場規模（按年齡層別分類）及複合年成長率（2025-2032 年）
- 市場概覽
- 成人
- 孩子們
全球腎臟病市場規模及複合年成長率（2025-2032）
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
- 亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
- 拉丁美洲
- 巴西
- 其他拉丁美洲地區
- 中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區
競爭資訊
- 前五大公司對比
- 主要企業的市場定位（2024 年）
- 主要市場參與者所採取的策略
- 近期市場趨勢
- 公司市佔率分析（2024 年）
- 主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2022-2024年營收年比比較
主要企業簡介
- Fresenius Medical Care AG & Co. KGaA（Germany）
- Baxter International Inc.（USA）
- Boston Scientific Corporation（USA）
- B. Braun Melsungen AG（Germany）
- Johnson & Johnson MedTech（USA）
- Medtronic PLC（Ireland）
- Olympus Corporation（Japan）
- Intuitive Surgical（USA）
- Coloplast A/S（Denmark）
- Teleflex Incorporated（USA）
- Becton, Dickinson and Company（BD）（USA）
- Cook Medical（USA）
- Stryker Corporation（USA）
- KARL STORZ SE & Co. KG（Germany）
- Dornier MedTech（Germany/USA）
- Nipro Corporation（Japan）
- Asahi Kasei Corporation（Japan）
- Cardinal Health（USA）
- Convatec Group PLC（UK）
- Richard Wolf GmbH（Germany）
結論與建議
Global Hydronephrosis Market size was valued at USD 2.3 billion in 2023 and is poised to grow from USD 2.42 billion in 2024 to USD 3.6 billion by 2032, growing at a CAGR of 5.1% during the forecast period (2025-2032).
The rising incidence of urinary tract obstructions, such as kidney stones, congenital anomalies, and tumors, is significantly influencing the global hydronephrosis market. These conditions hinder urine flow, leading to kidney swelling and deterioration, which prompts patients to seek diagnostic and therapeutic options, including minimally invasive techniques and surgical interventions. Contributing factors like lifestyle changes, dietary habits, and aging populations are intensifying the demand for advanced hydronephrosis management solutions worldwide. Concurrently, the proliferation of sophisticated imaging technologies, such as ultrasound, CT scans, and MRI, enables precise, non-invasive examination of kidney structures. This permits early diagnosis and appropriate intervention, minimizing complications and enhancing patient outcomes. The accessibility of affordable imaging devices further bolsters this market, driving growth and attracting investment opportunities.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hydronephrosis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Hydronephrosis Market Segments Analysis
Global Hydronephrosis Market is segmented by Type, Indication, Diagnosis, Treatment, Age Group and region. Based on Type, the market is segmented into Unilateral hydronephrosis and Bilateral hydronephrosis. Based on Indication, the market is segmented into Intrinsic and Extrinsic. Based on Diagnosis, the market is segmented into Laboratory tests and Imaging. Based on Treatment, the market is segmented into Shock wave lithotripsy, Laparoscopy, Bladder catheterization, Steroid therapy and Other treatment types. Based on Age Group, the market is segmented into Adult and Pediatric. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Hydronephrosis Market
The global hydronephrosis market is significantly driven by the rising prevalence of urinary tract obstructions such as kidney stones, congenital disorders, and tumors. These medical issues result in urine buildup, kidney enlargement, and compromised renal function, leading to an increased demand for innovative diagnostic technologies and efficient treatment options. As healthcare systems strive to address these challenges, the need for cutting-edge solutions continues to propel market expansion on a global scale. The heightened awareness and focus on managing hydronephrosis further contribute to the growth trajectory of this market segment, emphasizing the importance of timely intervention and advanced care strategies.
Restraints in the Global Hydronephrosis Market
The Global Hydronephrosis market faces significant constraints due to the lack of public awareness regarding kidney disorders in many developing countries, coupled with the limited access to early screening programs. This deficiency in awareness often leads to delayed diagnoses, which in turn undermines the effectiveness of treatments for hydronephrosis. As timely detection is crucial for optimal intervention, the resulting decrease in treatment efficacy restricts the demand for advanced diagnostic and therapeutic options. Consequently, these factors pose considerable challenges to market growth and expansion in these underserved regions, limiting the overall progress of the Hydronephrosis market on a global scale.
Market Trends of the Global Hydronephrosis Market
The Global Hydronephrosis market is witnessing a notable trend towards enhanced pediatric focus, particularly in addressing congenital urinary tract obstructions. Advances in AI-assisted imaging and early screening methodologies are revolutionizing detection capabilities, allowing for timely and accurate interventions in infants and children. This heightened emphasis on pediatric care not only fosters improved long-term kidney health outcomes but also broadens the spectrum of specialized treatment options available. Consequently, this trend is generating significant market opportunities for innovative diagnostic and therapeutic solutions tailored specifically for the pediatric population, elevating the overall growth potential within the hydronephrosis market landscape.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
Global Hydronephrosis Market Size by Type & CAGR (2025-2032)
- Market Overview
- Unilateral hydronephrosis
- Bilateral hydronephrosis
Global Hydronephrosis Market Size by Indication & CAGR (2025-2032)
- Market Overview
- Intrinsic
- Acute unilateral obstructive uropathy
- Kidney stone
- Bladder cancer
- Bladder stones
- Urethral stricture
- Pelvic organ prolapses
- Other intrinsic indications
- Extrinsic
- Retroperitoneal fibrosis
- Ovarian vein syndrome
- Other extrinsic indications
Global Hydronephrosis Market Size by Diagnosis & CAGR (2025-2032)
- Market Overview
- Laboratory tests
- Urinalysis
- Complete blood count
- Electrolyte analysis
- Other laboratory tests
- Imaging
- Ultrasound
- Intravenous pyelography
- KUB X-Rays
- CT-scan
- Other imaging types
Global Hydronephrosis Market Size by Treatment & CAGR (2025-2032)
- Market Overview
- Shock wave lithotripsy
- Laparoscopy
- Bladder catheterization
- Steroid therapy
- Other treatment types
Global Hydronephrosis Market Size by Age Group & CAGR (2025-2032)
- Market Overview
- Adult
- Pediatric
Global Hydronephrosis Market Size & CAGR (2025-2032)
- North America (Type, Indication, Diagnosis, Treatment, Age Group)
- US
- Canada
- Europe (Type, Indication, Diagnosis, Treatment, Age Group)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Type, Indication, Diagnosis, Treatment, Age Group)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Type, Indication, Diagnosis, Treatment, Age Group)
- Brazil
- Rest of Latin America
- Middle East & Africa (Type, Indication, Diagnosis, Treatment, Age Group)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Fresenius Medical Care AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Baxter International Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson MedTech (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Intuitive Surgical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Coloplast A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teleflex Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cook Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- KARL STORZ SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dornier MedTech (Germany/USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Asahi Kasei Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardinal Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Convatec Group PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Richard Wolf GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
